164 related articles for article (PubMed ID: 3184986)
1. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes.
Swolin B; Rödjer S; Westin J
Am J Hematol; 1990 Jul; 34(3):175-80. PubMed ID: 2363412
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
[TBL] [Abstract][Full Text] [Related]
4. Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins.
Baines P; Bowen D; Jacobs A
Leuk Res; 1990; 14(3):247-53. PubMed ID: 1690828
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic evidence for a clonal involvement of granulocyte-macrophage and erythroid lineages in a patient with refractory anaemia.
Okuda T; Yokota S; Maekawa T; Sonoda Y; Taniwaki M; Misawa S; Takino T; Abe T
Acta Haematol; 1988; 80(2):110-5. PubMed ID: 3138872
[TBL] [Abstract][Full Text] [Related]
6. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
Backx B; Broeders L; Touw I; Löwenberg B
Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
[TBL] [Abstract][Full Text] [Related]
7. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
[TBL] [Abstract][Full Text] [Related]
8. MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones.
Ohmori S; Ohmori M; Yamagishi M; Okuma M
Br J Haematol; 1993 Mar; 83(3):388-91. PubMed ID: 8485044
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow cultures and prognosis in primary myelodysplastic syndromes.
Korthout M; De Bock R; van Bockstaele D; Peetermans M
Leuk Res; 1990; 14(1):85-9. PubMed ID: 2304356
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
Tennant GB; Jacobs A; Bailey-Wood R
Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic evidence for involvement of erythroid and granulocyte/macrophage progenitors in an infant with monosomy 7 syndrome presenting de novo.
Tachibana N; Raimondi SC; Santana VM; Dow LW
Med Pediatr Oncol; 1988; 16(2):118-22. PubMed ID: 3352534
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haematopoietic progenitor cells: contribution of monocyte-derived lipid containing macrophages (MDLM).
Ohmori M; Ueda Y; Masutani H; Hirama T; Anzai N; Yoshida Y; Okuma M
Br J Haematol; 1992 May; 81(1):67-72. PubMed ID: 1520627
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
16. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders.
Yuo A; Miyazono K; Urabe A; Takaku F
Jpn J Cancer Res; 1990 Aug; 81(8):820-6. PubMed ID: 2118895
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells.
Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H
Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470
[TBL] [Abstract][Full Text] [Related]
19. Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes.
Delforge M; Raets V; Van Duppen V; Boogaerts M
Leuk Res; 2003 Jul; 27(7):593-8. PubMed ID: 12681358
[TBL] [Abstract][Full Text] [Related]
20. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
